Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
30
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| DeLucia David | Chief Financial Officer | 5 | $0 | $0 | 2025-12-06 |
| Wettig Thane | Interim CEO | 64 | $215.7K | $395.0K | 2025-12-06 |
| Schoeneck James A | Interim President | 61 | $224.0K | $1.42M | 2025-06-30 |
| Ho Maykin | Director | 20 | $0 | $148.6K | 2025-06-04 |
| Kauffman Michael | Director | 2 | $0 | $0 | 2025-06-04 |
| EDWARDS JEFFREY L | Director | 20 | $0 | $135.6K | 2025-06-04 |
| Chung Christine | SVP, China Operations | 145 | $0 | $5.86M | 2025-03-06 |
| Graham Juan | Chief Financial Officer | 39 | $0 | $337.3K | 2024-12-07 |
| Adib Deyaa | Chief Medical Officer | 1 | $25.9K | $0 | 2024-06-12 |
| Cravatt Benjamin | Director | 12 | $0 | $67.7K | 2024-06-05 |
| Blaug Suzanne | Director | 14 | $0 | $146.6K | 2024-06-05 |
| Lema Gerald | Director | 16 | $163.4K | $0 | 2024-06-05 |
| Brennan Aoife | Director | 12 | $0 | $81.4K | 2024-06-05 |
| Eisner Mark | Incoming Chief Medical Officer | 27 | $0 | $614.3K | 2023-09-06 |
| Henderson Jeffrey William | Director | 21 | $0 | $133.4K | 2023-09-01 |
| Conterno Enrique A | Chief Executive Officer | 32 | $988.9K | $1.82M | 2023-07-07 |
| KEARNS THOMAS F JR | Director | 58 | $0 | $4.61M | 2021-09-15 |
| Cotroneo Pat | VP, Finance and CFO | 227 | $0 | $23.43M | 2021-09-07 |
| Kurkijarvi Kalevi | Director | 128 | $0 | $8.05M | 2021-05-26 |
| RIGGS RORY B | Director | 31 | $0 | $6.13M | 2021-05-26 |
| Kouchakji Elias | SVP, Clinical Dev, Drug Safety | 17 | $0 | $129.3K | 2021-03-08 |
| Yu K Peony | VP, Clinical Development | 137 | $0 | $13.40M | 2020-12-16 |
| Rosenkranz Roberto Pedro | Director | 68 | $0 | $1.33M | 2020-06-09 |
| Neff Thomas B | Chief Executive Officer | 861 | $0 | $139.07M | 2019-08-22 |
| Tamura Toshinari | Director | 33 | $0 | $2.88M | 2019-06-05 |
| Routti Jorma | Director | 61 | $0 | $3.82M | 2019-03-26 |
| STERN JULIAN N | Director | 11 | $0 | $0 | 2016-06-08 |
| VALONE FRANK H MD | Chief Medical Officer | 52 | $0 | $1.77M | 2016-04-01 |
| MADERO MIGUEL | Director | 27 | $0 | $1.80M | 2015-12-08 |
| Astellas Pharma Inc. | Other | 4 | $0 | $0 | 2014-11-19 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Wettig Thane | CEO | F Tax w/h | 2025-12-06 | 2025-12-09 | 259 | $8.42 | $2.2K | 24,680 | SEC↗ |
| DeLucia David | Chief Financial Officer | F Tax w/h | 2025-12-06 | 2025-12-09 | 52 | $8.42 | $438 | 4,489 | SEC↗ |
| Wettig Thane | CEO | P Buy | 2025-11-17 | 2025-11-17 | 2,700 | $9.10 | $24.6K | 24,939 | SEC↗ |
| Wettig Thane | CEO | P Buy | 2025-11-13 | 2025-11-17 | 1,000 | $9.18 | $9.2K | 22,239 | SEC↗ |
| Wettig Thane | CEO | F Tax w/h | 2025-09-06 | 2025-09-09 | 248 | $12.10 | $3.0K | 21,239 | SEC↗ |
| DeLucia David | Chief Financial Officer | F Tax w/h | 2025-09-06 | 2025-09-09 | 53 | $12.10 | $641 | 4,541 | SEC↗ |
| Schoeneck James A | Director | P Buy | 2025-06-30 | 2025-07-02 | 23,567 | $5.07 | $119.5K | 39,666 | SEC↗ |
| Wettig Thane | CEO | F Tax w/h | 2025-06-06 | 2025-09-09 | 246 | $7.83 | $1.9K | 21,487 | SEC↗ |
| DeLucia David | Chief Financial Officer | F Tax w/h | 2025-06-06 | 2025-09-09 | 51 | $7.83 | $399 | 4,594 | SEC↗ |
| Kauffman Michael | Director | A Award deriv | 2025-06-04 | 2025-06-06 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Kauffman Michael | Director | A Award deriv | 2025-06-04 | 2025-06-06 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Schoeneck James A | Director | A Award deriv | 2025-06-04 | 2025-06-06 | 120,000 | — | $0 | 120,000 | SEC↗ |
| EDWARDS JEFFREY L | Director | A Award deriv | 2025-06-04 | 2025-06-06 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Ho Maykin | Director | A Award deriv | 2025-06-04 | 2025-06-06 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Wettig Thane | CEO | P Buy | 2025-03-24 | 2025-03-25 | 145,000 | $0.35 | $50.8K | 543,329 | SEC↗ |
| Schoeneck James A | Director | P Buy | 2025-03-21 | 2025-03-24 | 50,000 | $0.34 | $17.0K | 373,722 | SEC↗ |
| Schoeneck James A | Director | P Buy | 2025-03-20 | 2025-03-24 | 250,000 | $0.35 | $87.5K | 323,722 | SEC↗ |
| DeLucia David | Chief Financial Officer | F Tax w/h | 2025-03-06 | 2025-03-07 | 2,325 | $0.39 | $907 | 116,137 | SEC↗ |
| Chung Christine | SVP, CHINA OPERATIONS | F Tax w/h | 2025-03-06 | 2025-03-07 | 7,008 | $0.39 | $2.7K | 294,544 | SEC↗ |
| Chung Christine | SVP, CHINA OPERATIONS | F Tax w/h | 2025-03-06 | 2025-03-07 | 422 | $0.39 | $165 | 294,903 | SEC↗ |
| Chung Christine | SVP, CHINA OPERATIONS | A Award | 2025-03-06 | 2025-03-07 | 781 | — | $0 | 295,325 | SEC↗ |
| Wettig Thane | CEO | F Tax w/h | 2025-03-06 | 2025-03-07 | 22,038 | $0.39 | $8.6K | 397,915 | SEC↗ |
| Wettig Thane | CEO | F Tax w/h | 2025-03-06 | 2025-03-07 | 367 | $0.39 | $143 | 398,329 | SEC↗ |
| Wettig Thane | CEO | A Award | 2025-03-06 | 2025-03-07 | 781 | — | $0 | 398,696 | SEC↗ |
| Wettig Thane | CEO | A Award deriv | 2025-01-09 | 2025-01-10 | 1,300,000 | — | $0 | 1,300,000 | SEC↗ |
| DeLucia David | Chief Financial Officer | A Award deriv | 2025-01-09 | 2025-01-10 | 525,000 | — | $0 | 525,000 | SEC↗ |
| Graham Juan | CHIEF FINANCIAL OFFICER | F Tax w/h | 2024-12-07 | 2024-12-09 | 1,066 | $0.34 | $362 | 164,863 | SEC↗ |
| Chung Christine | SVP, CHINA OPERATIONS | F Tax w/h | 2024-12-06 | 2024-12-09 | 2,792 | $0.34 | $949 | 301,552 | SEC↗ |
| Wettig Thane | CEO | F Tax w/h | 2024-12-06 | 2024-12-09 | 2,363 | $0.34 | $803 | 419,953 | SEC↗ |
| Graham Juan | CHIEF FINANCIAL OFFICER | F Tax w/h | 2024-12-06 | 2024-12-09 | 1,446 | $0.34 | $492 | 165,929 | SEC↗ |
| Graham Juan | CHIEF FINANCIAL OFFICER | F Tax w/h | 2024-09-07 | 2024-09-09 | 1,065 | $0.39 | $415 | 167,375 | SEC↗ |
| Chung Christine | SVP, CHINA OPERATIONS | F Tax w/h | 2024-09-06 | 2024-09-09 | 17,395 | $0.39 | $6.8K | 304,344 | SEC↗ |
| Wettig Thane | CEO | F Tax w/h | 2024-09-06 | 2024-09-09 | 2,363 | $0.39 | $922 | 422,316 | SEC↗ |
| Graham Juan | CHIEF FINANCIAL OFFICER | F Tax w/h | 2024-09-06 | 2024-09-09 | 16,050 | $0.39 | $6.3K | 168,440 | SEC↗ |
| Wettig Thane | CEO | F Tax w/h | 2024-08-01 | 2024-08-05 | 20,840 | $0.47 | $9.8K | 424,679 | SEC↗ |
| Wettig Thane | CEO | F Tax w/h | 2024-06-22 | 2024-06-25 | 782 | $1.13 | $884 | 445,519 | SEC↗ |
| Adib Deyaa | Chief Medical Officer | P Buy | 2024-06-12 | 2024-06-13 | 22,123 | $1.17 | $25.9K | 82,123 | SEC↗ |
| Graham Juan | CHIEF FINANCIAL OFFICER | F Tax w/h | 2024-06-07 | 2024-06-10 | 1,182 | $1.10 | $1.3K | 184,490 | SEC↗ |
| Wettig Thane | CEO | F Tax w/h | 2024-06-06 | 2024-06-07 | 2,255 | $1.19 | $2.7K | 446,301 | SEC↗ |
| Chung Christine | SVP, CHINA OPERATIONS | F Tax w/h | 2024-06-06 | 2024-06-07 | 19,289 | $1.19 | $23.0K | 321,739 | SEC↗ |
| Graham Juan | CHIEF FINANCIAL OFFICER | F Tax w/h | 2024-06-06 | 2024-06-10 | 17,797 | $1.19 | $21.2K | 185,672 | SEC↗ |
| Blaug Suzanne | Director | A Award deriv | 2024-06-05 | 2024-06-06 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Brennan Aoife | Director | A Award deriv | 2024-06-05 | 2024-06-06 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Cravatt Benjamin | Director | A Award deriv | 2024-06-05 | 2024-06-06 | 70,000 | — | $0 | 70,000 | SEC↗ |
| EDWARDS JEFFREY L | Director | A Award deriv | 2024-06-05 | 2024-06-06 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Ho Maykin | Director | A Award deriv | 2024-06-05 | 2024-06-06 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Lema Gerald | Director | A Award deriv | 2024-06-05 | 2024-06-06 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Schoeneck James A | Director | A Award deriv | 2024-06-05 | 2024-06-06 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Wettig Thane | CEO | F Tax w/h | 2024-05-01 | 2024-05-02 | 20,840 | $1.17 | $24.4K | 448,556 | SEC↗ |
| Wettig Thane | CEO | F Tax w/h | 2024-03-22 | 2024-03-25 | 782 | $2.58 | $2.0K | 469,396 | SEC↗ |
| Graham Juan | CHIEF FINANCIAL OFFICER | F Tax w/h | 2024-03-07 | 2024-03-08 | 1,181 | $1.79 | $2.1K | 203,469 | SEC↗ |
| Wettig Thane | CEO | P Buy | 2024-03-07 | 2024-03-11 | 50,000 | $1.91 | $95.5K | 470,178 | SEC↗ |
| Chung Christine | SVP, CHINA OPERATIONS | F Tax w/h | 2024-03-06 | 2024-03-08 | 422 | $1.87 | $789 | 341,028 | SEC↗ |
| Chung Christine | SVP, CHINA OPERATIONS | F Tax w/h | 2024-03-06 | 2024-03-08 | 23,168 | $1.87 | $43.3K | 340,669 | SEC↗ |
| Chung Christine | SVP, CHINA OPERATIONS | A Award | 2024-03-06 | 2024-03-08 | 781 | — | $0 | 341,450 | SEC↗ |
| Wettig Thane | CEO | F Tax w/h | 2024-03-06 | 2024-03-08 | 4,209 | $1.87 | $7.9K | 419,723 | SEC↗ |
| Wettig Thane | CEO | A Award | 2024-03-06 | 2024-03-08 | 781 | — | $0 | 420,504 | SEC↗ |
| Wettig Thane | CEO | F Tax w/h | 2024-03-06 | 2024-03-08 | 326 | $1.87 | $610 | 420,178 | SEC↗ |
| Graham Juan | CHIEF FINANCIAL OFFICER | F Tax w/h | 2024-03-06 | 2024-03-08 | 20,327 | $1.87 | $38.0K | 204,291 | SEC↗ |
| Graham Juan | CHIEF FINANCIAL OFFICER | A Award | 2024-03-06 | 2024-03-08 | 781 | — | $0 | 205,072 | SEC↗ |
| Graham Juan | CHIEF FINANCIAL OFFICER | F Tax w/h | 2024-03-06 | 2024-03-08 | 422 | $1.87 | $789 | 204,650 | SEC↗ |
| Graham Juan | CHIEF FINANCIAL OFFICER | A Award deriv | 2024-02-21 | 2024-02-23 | 260,000 | — | $0 | 260,000 | SEC↗ |
| Chung Christine | SVP, CHINA OPERATIONS | A Award deriv | 2024-02-21 | 2024-02-23 | 143,000 | — | $0 | 143,000 | SEC↗ |
| Wettig Thane | CEO | A Award deriv | 2024-02-21 | 2024-02-23 | 834,000 | — | $0 | 834,000 | SEC↗ |
| Graham Juan | CHIEF FINANCIAL OFFICER | A Award | 2024-02-21 | 2024-02-23 | 52,000 | — | $0 | 224,618 | SEC↗ |
| Chung Christine | SVP, CHINA OPERATIONS | A Award | 2024-02-21 | 2024-02-23 | 29,000 | — | $0 | 363,837 | SEC↗ |
| Wettig Thane | CEO | A Award | 2024-02-21 | 2024-02-23 | 166,000 | — | $0 | 423,932 | SEC↗ |
| Wettig Thane | CEO | F Tax w/h | 2024-02-01 | 2024-02-05 | 23,490 | $2.37 | $55.7K | 257,932 | SEC↗ |
| Wettig Thane | CEO | F Tax w/h | 2023-12-22 | 2023-12-26 | 819 | $0.76 | $622 | 281,422 | SEC↗ |
| Graham Juan | Chief Financial Officer | F Tax w/h | 2023-12-07 | 2023-12-11 | 1,085 | $0.62 | $673 | 172,618 | SEC↗ |
| Wettig Thane | CEO | F Tax w/h | 2023-12-06 | 2023-12-11 | 1,680 | $0.58 | $974 | 282,241 | SEC↗ |
| Chung Christine | SVP, China Operations | F Tax w/h | 2023-12-06 | 2023-12-11 | 18,182 | $0.58 | $10.5K | 334,837 | SEC↗ |
| Graham Juan | Chief Financial Officer | F Tax w/h | 2023-12-06 | 2023-12-11 | 15,573 | $0.58 | $9.0K | 173,703 | SEC↗ |
| Wettig Thane | CEO | F Tax w/h | 2023-11-01 | 2023-11-03 | 21,841 | $0.55 | $12.0K | 283,921 | SEC↗ |
| Wettig Thane | Interim CEO | F Tax w/h | 2023-09-22 | 2023-09-25 | 819 | $0.79 | $647 | 305,762 | SEC↗ |
| Graham Juan | Chief Financial Officer | F Tax w/h | 2023-09-07 | 2023-09-08 | 1,096 | $0.99 | $1.1K | 189,276 | SEC↗ |
| Chung Christine | SVP, China Operations | F Tax w/h | 2023-09-06 | 2023-09-08 | 3,308 | $0.96 | $3.2K | 353,019 | SEC↗ |
| Eisner Mark | EVP, Chief Medical Officer | F Tax w/h | 2023-09-06 | 2023-09-08 | 1,860 | $0.96 | $1.8K | 159,917 | SEC↗ |
| Wettig Thane | Interim CEO | F Tax w/h | 2023-09-06 | 2023-09-08 | 1,680 | $0.96 | $1.6K | 306,581 | SEC↗ |
| Graham Juan | Chief Financial Officer | F Tax w/h | 2023-09-06 | 2023-09-08 | 711 | $0.96 | $683 | 190,372 | SEC↗ |
| Henderson Jeffrey William | Director | S Sale | 2023-09-01 | 2023-09-06 | 2,000 | $1.03 | $2.1K | 28,866 | SEC↗ |
| Eisner Mark | EVP, Chief Medical Officer | F Tax w/h | 2023-09-01 | 2023-09-06 | 1,085 | $1.06 | $1.2K | 161,777 | SEC↗ |
| Chung Christine | SVP, China Operations | A Award deriv | 2023-08-30 | 2023-09-01 | 220,000 | — | $0 | 220,000 | SEC↗ |
| Graham Juan | Chief Financial Officer | A Award deriv | 2023-08-30 | 2023-09-01 | 220,000 | — | $0 | 220,000 | SEC↗ |
| Chung Christine | SVP, China Operations | A Award | 2023-08-30 | 2023-09-01 | 120,000 | — | $0 | 356,327 | SEC↗ |
| Graham Juan | Chief Financial Officer | A Award | 2023-08-30 | 2023-09-01 | 120,000 | — | $0 | 191,083 | SEC↗ |
| Schoeneck James A | Director | A Award deriv | 2023-08-10 | 2023-08-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Wettig Thane | Chief Commercial Officer | A Award deriv | 2023-08-07 | 2023-08-09 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Wettig Thane | Chief Commercial Officer | A Award | 2023-08-07 | 2023-08-09 | 200,000 | — | $0 | 308,261 | SEC↗ |
| Henderson Jeffrey William | Director | S Sale | 2023-08-04 | 2023-08-08 | 2,000 | $1.91 | $3.8K | 30,866 | SEC↗ |
| Henderson Jeffrey William | Director | S Sale | 2023-07-11 | 2023-07-13 | 2,000 | $2.69 | $5.4K | 32,866 | SEC↗ |
| Conterno Enrique A | Chief Executive Officer | S Sale | 2023-07-07 | 2023-07-10 | 1,880 | $2.80 | $5.3K | 374,722 | SEC↗ |
| Wettig Thane | Chief Commercial Officer | S Sale | 2023-06-23 | 2023-06-26 | 791 | $16.53 | $13.1K | 108,261 | SEC↗ |
| Chung Christine | SVP, China Operations | S Sale | 2023-06-14 | 2023-06-15 | 1,000 | $17.46 | $17.5K | 236,327 | SEC↗ |
| Chung Christine | SVP, China Operations | S Sale | 2023-06-14 | 2023-06-15 | 5,250 | $16.66 | $87.5K | 237,327 | SEC↗ |
| Chung Christine | SVP, China Operations | S Sale | 2023-06-13 | 2023-06-15 | 6,250 | $17.60 | $110.0K | 242,577 | SEC↗ |
| EDWARDS JEFFREY L | Director | S Sale | 2023-06-09 | 2023-06-09 | 3,265 | $16.74 | $54.7K | 38,601 | SEC↗ |
| EDWARDS JEFFREY L | Director | S Sale | 2023-06-09 | 2023-06-09 | 4,624 | $17.51 | $81.0K | 33,977 | SEC↗ |
| Blaug Suzanne | Director | S Sale | 2023-06-09 | 2023-06-09 | 5,169 | $17.51 | $90.5K | 29,594 | SEC↗ |
| Blaug Suzanne | Director | S Sale | 2023-06-09 | 2023-06-09 | 3,351 | $16.73 | $56.1K | 34,763 | SEC↗ |
| Brennan Aoife | Director | S Sale | 2023-06-09 | 2023-06-09 | 1,994 | $16.74 | $33.4K | 30,686 | SEC↗ |
| Brennan Aoife | Director | S Sale | 2023-06-09 | 2023-06-09 | 2,739 | $17.52 | $48.0K | 27,947 | SEC↗ |
| Cravatt Benjamin | Director | S Sale | 2023-06-09 | 2023-06-09 | 2,178 | $17.51 | $38.1K | 28,736 | SEC↗ |
| Cravatt Benjamin | Director | S Sale | 2023-06-09 | 2023-06-09 | 1,766 | $16.75 | $29.6K | 30,914 | SEC↗ |
| Henderson Jeffrey William | Director | S Sale | 2023-06-08 | 2023-06-09 | 4,994 | $17.69 | $88.3K | 34,866 | SEC↗ |
| Henderson Jeffrey William | Director | S Sale | 2023-06-08 | 2023-06-09 | 2,006 | $16.87 | $33.8K | 39,860 | SEC↗ |
| Ho Maykin | Director | S Sale | 2023-06-08 | 2023-06-09 | 2,295 | $16.79 | $38.5K | 37,726 | SEC↗ |
| Ho Maykin | Director | S Sale | 2023-06-08 | 2023-06-09 | 6,225 | $17.68 | $110.1K | 31,501 | SEC↗ |
| Schoeneck James A | Director | A Award deriv | 2023-06-07 | 2023-06-09 | 12,666 | — | $0 | 12,666 | SEC↗ |
| Henderson Jeffrey William | Director | A Award deriv | 2023-06-07 | 2023-06-09 | 12,666 | — | $0 | 12,666 | SEC↗ |
| EDWARDS JEFFREY L | Director | A Award deriv | 2023-06-07 | 2023-06-09 | 12,666 | — | $0 | 12,666 | SEC↗ |
| Lema Gerald | Director | A Award deriv | 2023-06-07 | 2023-06-09 | 12,666 | — | $0 | 12,666 | SEC↗ |
| Ho Maykin | Director | A Award deriv | 2023-06-07 | 2023-06-09 | 12,666 | — | $0 | 12,666 | SEC↗ |
| Blaug Suzanne | Director | A Award deriv | 2023-06-07 | 2023-06-09 | 12,666 | — | $0 | 12,666 | SEC↗ |
| Brennan Aoife | Director | A Award deriv | 2023-06-07 | 2023-06-09 | 12,666 | — | $0 | 12,666 | SEC↗ |
| Cravatt Benjamin | Director | A Award deriv | 2023-06-07 | 2023-06-09 | 12,666 | — | $0 | 12,666 | SEC↗ |
| Conterno Enrique A | Chief Executive Officer | S Sale | 2023-06-07 | 2023-06-09 | 2,791 | $17.04 | $47.6K | 382,708 | SEC↗ |
| Conterno Enrique A | Chief Executive Officer | S Sale | 2023-06-07 | 2023-06-09 | 6,106 | $17.04 | $104.0K | 376,602 | SEC↗ |
| Eisner Mark | EVP, Chief Medical Officer | S Sale | 2023-06-07 | 2023-06-09 | 2,042 | $17.04 | $34.8K | 162,862 | SEC↗ |
| Chung Christine | SVP, China Operations | S Sale | 2023-06-07 | 2023-06-09 | 1,362 | $17.04 | $23.2K | 251,098 | SEC↗ |
| Chung Christine | SVP, China Operations | S Sale | 2023-06-07 | 2023-06-09 | 739 | $17.04 | $12.6K | 250,359 | SEC↗ |
| Chung Christine | SVP, China Operations | S Sale | 2023-06-07 | 2023-06-09 | 1,532 | $17.04 | $26.1K | 248,827 | SEC↗ |
| Graham Juan | Chief Financial Officer | S Sale | 2023-06-07 | 2023-06-09 | 1,050 | $16.95 | $17.8K | 71,818 | SEC↗ |
| Graham Juan | Chief Financial Officer | S Sale | 2023-06-07 | 2023-06-09 | 735 | $17.04 | $12.5K | 71,083 | SEC↗ |
| Wettig Thane | Chief Commercial Officer | S Sale | 2023-06-07 | 2023-06-09 | 472 | $17.04 | $8.0K | 112,681 | SEC↗ |
| Wettig Thane | Chief Commercial Officer | S Sale | 2023-06-07 | 2023-06-09 | 1,286 | $17.04 | $21.9K | 111,395 | SEC↗ |
| Schoeneck James A | Director | A Award | 2023-06-07 | 2023-06-09 | 8,289 | — | $0 | 28,766 | SEC↗ |
| Schoeneck James A | Director | S Sale | 2023-06-07 | 2023-06-09 | 7,100 | $18.03 | $128.0K | 73,722 | SEC↗ |
| Henderson Jeffrey William | Director | A Award | 2023-06-07 | 2023-06-09 | 8,289 | — | $0 | 41,866 | SEC↗ |
| EDWARDS JEFFREY L | Director | A Award | 2023-06-07 | 2023-06-09 | 8,289 | — | $0 | 41,866 | SEC↗ |
| Lema Gerald | Director | A Award | 2023-06-07 | 2023-06-09 | 8,289 | — | $0 | 28,766 | SEC↗ |
| Ho Maykin | Director | A Award | 2023-06-07 | 2023-06-09 | 8,289 | — | $0 | 40,021 | SEC↗ |
| Blaug Suzanne | Director | A Award | 2023-06-07 | 2023-06-09 | 8,289 | — | $0 | 38,114 | SEC↗ |
| Brennan Aoife | Director | A Award | 2023-06-07 | 2023-06-09 | 8,289 | — | $0 | 32,680 | SEC↗ |
| Cravatt Benjamin | Director | A Award | 2023-06-07 | 2023-06-09 | 8,289 | — | $0 | 32,680 | SEC↗ |
| Wettig Thane | Chief Commercial Officer | S Sale | 2023-06-07 | 2023-06-22 | 1,286 | $17.04 | $21.9K | 109,052 | SEC↗ |
| Wettig Thane | Chief Commercial Officer | S Sale | 2023-06-07 | 2023-06-22 | 472 | $17.04 | $8.0K | 110,338 | SEC↗ |
| Eisner Mark | EVP, Chief Medical Officer | S Sale | 2023-06-02 | 2023-06-05 | 1,090 | $18.83 | $20.5K | 164,904 | SEC↗ |
| Conterno Enrique A | Chief Executive Officer | S Sale | 2023-04-10 | 2023-04-11 | 1,869 | $19.52 | $36.5K | 382,999 | SEC↗ |
| Chung Christine | SVP, China Operations | S Sale | 2023-04-04 | 2023-04-06 | 6,590 | $18.78 | $123.8K | 252,460 | SEC↗ |
| Eisner Mark | Chief Medical Officer | S Sale | 2023-04-04 | 2023-04-06 | 9,182 | $18.78 | $172.4K | 165,994 | SEC↗ |
| Wettig Thane | Chief Commercial Officer | S Sale | 2023-03-23 | 2023-03-24 | 905 | $18.71 | $16.9K | 110,653 | SEC↗ |
| Wettig Thane | Chief Commercial Officer | G Gift | 2023-03-20 | 2023-03-29 | 1,000 | — | $0 | 1,000 | SEC↗ |
| Wettig Thane | Chief Commercial Officer | G Gift | 2023-03-20 | 2023-03-29 | 2,343 | — | $0 | 108,310 | SEC↗ |
| Wettig Thane | Chief Commercial Officer | S Sale | 2023-03-10 | 2023-03-10 | 2,938 | $20.20 | $59.3K | 116,289 | SEC↗ |
| Wettig Thane | Chief Commercial Officer | S Sale | 2023-03-10 | 2023-03-10 | 4,731 | $20.20 | $95.6K | 111,558 | SEC↗ |
| Graham Juan | Chief Financial Officer | S Sale | 2023-03-10 | 2023-03-10 | 2,344 | $20.20 | $47.3K | 72,868 | SEC↗ |
| Graham Juan | Chief Financial Officer | S Sale | 2023-03-10 | 2023-03-10 | 1,456 | $20.20 | $29.4K | 75,212 | SEC↗ |
| Graham Juan | Chief Financial Officer | S Sale | 2023-03-10 | 2023-03-10 | 1,112 | $20.20 | $22.5K | 76,668 | SEC↗ |
| Eisner Mark | Chief Medical Officer | S Sale | 2023-03-10 | 2023-03-10 | 3,885 | $20.20 | $78.5K | 181,431 | SEC↗ |
| Eisner Mark | Chief Medical Officer | S Sale | 2023-03-10 | 2023-03-10 | 6,255 | $20.20 | $126.4K | 175,176 | SEC↗ |
| Conterno Enrique A | Chief Executive Officer | S Sale | 2023-03-10 | 2023-03-10 | 19,486 | $20.20 | $393.6K | 384,868 | SEC↗ |
| Conterno Enrique A | Chief Executive Officer | S Sale | 2023-03-10 | 2023-03-10 | 12,103 | $20.20 | $244.5K | 404,357 | SEC↗ |
| Chung Christine | SVP, China Operations | S Sale | 2023-03-10 | 2023-03-10 | 4,692 | $20.20 | $94.8K | 261,964 | SEC↗ |
| Chung Christine | SVP, China Operations | S Sale | 2023-03-10 | 2023-03-10 | 2,914 | $20.20 | $58.9K | 259,050 | SEC↗ |
| Conterno Enrique A | Chief Executive Officer | S Sale | 2023-03-10 | 2023-03-23 | 19,489 | $20.20 | $393.7K | 384,868 | SEC↗ |
| Wettig Thane | Chief Commercial Officer | A Award | 2023-03-08 | 2023-03-10 | 9,338 | — | $0 | 119,227 | SEC↗ |
| Wettig Thane | Chief Commercial Officer | A Award | 2023-03-08 | 2023-03-10 | 5,799 | — | $0 | 109,889 | SEC↗ |
| Wettig Thane | Chief Commercial Officer | S Sale | 2023-03-08 | 2023-03-10 | 6,265 | $21.16 | $132.6K | 104,090 | SEC↗ |
| Graham Juan | Chief Financial Officer | S Sale | 2023-03-08 | 2023-03-10 | 2,749 | $21.16 | $58.2K | 70,213 | SEC↗ |
| Graham Juan | Chief Financial Officer | A Award | 2023-03-08 | 2023-03-10 | 4,668 | — | $0 | 77,780 | SEC↗ |
| Graham Juan | Chief Financial Officer | A Award | 2023-03-08 | 2023-03-10 | 2,899 | — | $0 | 73,112 | SEC↗ |
| Eisner Mark | Chief Medical Officer | S Sale | 2023-03-08 | 2023-03-10 | 7,363 | $21.16 | $155.8K | 165,133 | SEC↗ |
| Eisner Mark | Chief Medical Officer | A Award | 2023-03-08 | 2023-03-10 | 12,451 | — | $0 | 185,316 | SEC↗ |
| Eisner Mark | Chief Medical Officer | A Award | 2023-03-08 | 2023-03-10 | 7,732 | — | $0 | 172,865 | SEC↗ |
| Conterno Enrique A | Chief Executive Officer | S Sale | 2023-03-08 | 2023-03-10 | 24,672 | $21.16 | $522.1K | 356,111 | SEC↗ |
| Conterno Enrique A | Chief Executive Officer | A Award | 2023-03-08 | 2023-03-10 | 23,120 | — | $0 | 379,231 | SEC↗ |
| Conterno Enrique A | Chief Executive Officer | A Award | 2023-03-08 | 2023-03-10 | 37,229 | — | $0 | 416,460 | SEC↗ |
| Chung Christine | SVP, China Operations | S Sale | 2023-03-08 | 2023-03-10 | 8,354 | $21.16 | $176.8K | 251,519 | SEC↗ |
| Chung Christine | SVP, China Operations | A Award | 2023-03-08 | 2023-03-10 | 5,799 | — | $0 | 257,318 | SEC↗ |
| Chung Christine | SVP, China Operations | A Award | 2023-03-08 | 2023-03-10 | 9,338 | — | $0 | 266,656 | SEC↗ |
| Eisner Mark | Chief Medical Officer | S Sale | 2023-03-02 | 2023-03-06 | 1,187 | $21.87 | $26.0K | 172,496 | SEC↗ |
| Conterno Enrique A | Chief Executive Officer | A Award deriv | 2023-02-21 | 2023-02-23 | 143,100 | — | $0 | 143,100 | SEC↗ |
| Eisner Mark | Chief Medical Officer | A Award deriv | 2023-02-21 | 2023-02-23 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Chung Christine | SVP, China Operations | A Award deriv | 2023-02-21 | 2023-02-23 | 42,000 | — | $0 | 42,000 | SEC↗ |
| Graham Juan | Chief Financial Officer | A Award deriv | 2023-02-21 | 2023-02-23 | 42,000 | — | $0 | 42,000 | SEC↗ |
| Wettig Thane | Chief Commercial Officer | A Award deriv | 2023-02-21 | 2023-02-23 | 42,000 | — | $0 | 42,000 | SEC↗ |
| Conterno Enrique A | Chief Executive Officer | A Award | 2023-02-21 | 2023-02-23 | 85,300 | — | $0 | 380,783 | SEC↗ |
| Eisner Mark | Chief Medical Officer | A Award | 2023-02-21 | 2023-02-23 | 32,500 | — | $0 | 173,683 | SEC↗ |
| Chung Christine | SVP, China Operations | A Award | 2023-02-21 | 2023-02-23 | 25,000 | — | $0 | 259,873 | SEC↗ |
| Graham Juan | Chief Financial Officer | A Award | 2023-02-21 | 2023-02-23 | 25,000 | — | $0 | 72,962 | SEC↗ |
| Wettig Thane | Chief Commercial Officer | A Award | 2023-02-21 | 2023-02-23 | 25,000 | — | $0 | 110,355 | SEC↗ |
| Conterno Enrique A | Chief Executive Officer | S Sale | 2023-01-06 | 2023-01-10 | 1,538 | $19.95 | $30.7K | 295,483 | SEC↗ |
| Wettig Thane | Chief Commercial Officer | S Sale | 2022-12-23 | 2022-12-28 | 734 | $15.80 | $11.6K | 89,163 | SEC↗ |
| Graham Juan | Chief Financial Officer | S Sale | 2022-12-12 | 2022-12-14 | 1,407 | $14.50 | $20.4K | 53,703 | SEC↗ |
| Graham Juan | Chief Financial Officer | S Sale | 2022-12-12 | 2022-12-15 | 1,407 | $14.50 | $20.4K | 47,962 | SEC↗ |
| Graham Juan | Chief Financial Officer | S Sale | 2022-12-09 | 2022-12-14 | 781 | $14.90 | $11.6K | 55,110 | SEC↗ |
| Graham Juan | Chief Financial Officer | S Sale | 2022-12-09 | 2022-12-15 | 781 | $14.89 | $11.6K | 49,369 | SEC↗ |
| Chung Christine | SVP, China Operations | S Sale | 2022-12-08 | 2023-01-04 | 2,595 | $15.79 | $41.0K | 234,873 | SEC↗ |
| Conterno Enrique A | Chief Executive Officer | S Sale | 2022-12-08 | 2022-12-09 | 2,543 | $15.79 | $40.2K | 297,020 | SEC↗ |
| Wettig Thane | Chief Commercial Officer | S Sale | 2022-12-08 | 2022-12-09 | 382 | $15.79 | $6.0K | 89,897 | SEC↗ |
| Chung Christine | SVP, China Operations | S Sale | 2022-12-08 | 2022-12-09 | 1,096 | $15.79 | $17.3K | 237,705 | SEC↗ |
| Graham Juan | Chief Financial Officer | S Sale | 2022-12-08 | 2022-12-15 | 5,263 | $14.84 | $78.1K | 50,628 | SEC↗ |
| Graham Juan | Chief Financial Officer | S Sale | 2022-12-08 | 2022-12-15 | 478 | $15.47 | $7.4K | 50,150 | SEC↗ |
| Eisner Mark | Chief Medical Officer | F Tax w/h | 2022-12-01 | 2022-12-02 | 1,084 | $15.04 | $16.3K | 141,183 | SEC↗ |
| Conterno Enrique A | Chief Executive Officer | F Tax w/h | 2022-10-06 | 2022-10-11 | 1,296 | $14.26 | $18.5K | 299,563 | SEC↗ |
| Eisner Mark | Chief Medical Officer | F Tax w/h | 2022-09-30 | 2022-10-04 | 6,777 | $13.01 | $88.2K | 142,267 | SEC↗ |
| Chung Christine | SVP, China Operations | F Tax w/h | 2022-09-30 | 2022-10-04 | 4,683 | $13.01 | $60.9K | 238,801 | SEC↗ |
| Wettig Thane | Chief Commercial Officer | F Tax w/h | 2022-09-22 | 2022-09-26 | 655 | $12.26 | $8.0K | 90,279 | SEC↗ |
| Graham Juan | Chief Financial Officer | F Tax w/h | 2022-09-07 | 2022-09-08 | 3,009 | $12.62 | $38.0K | 55,891 | SEC↗ |
| Chung Christine | SVP, China Operations | F Tax w/h | 2022-09-06 | 2023-01-04 | 1,851 | $12.26 | $22.7K | 242,151 | SEC↗ |
| Conterno Enrique A | Chief Executive Officer | F Tax w/h | 2022-09-06 | 2022-09-08 | 1,772 | $12.26 | $21.7K | 300,859 | SEC↗ |
| Wettig Thane | Chief Commercial Officer | F Tax w/h | 2022-09-06 | 2022-09-08 | 360 | $12.26 | $4.4K | 90,934 | SEC↗ |
| Chung Christine | SVP, China Operations | F Tax w/h | 2022-09-06 | 2022-09-08 | 518 | $12.26 | $6.4K | 243,484 | SEC↗ |
| Eisner Mark | Chief Medical Officer | F Tax w/h | 2022-09-01 | 2022-09-02 | 756 | $13.09 | $9.9K | 149,044 | SEC↗ |
| Conterno Enrique A | Chief Executive Officer | F Tax w/h | 2022-07-06 | 2022-07-08 | 1,296 | $12.40 | $16.1K | 302,631 | SEC↗ |
| Wettig Thane | Chief Commercial Officer | F Tax w/h | 2022-06-22 | 2022-06-24 | 655 | $11.42 | $7.5K | 91,294 | SEC↗ |
| Schoeneck James A | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 25,684 | — | $0 | 25,684 | SEC↗ |
| Lema Gerald | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 25,684 | — | $0 | 25,684 | SEC↗ |
| Blaug Suzanne | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 25,684 | — | $0 | 25,684 | SEC↗ |
| Brennan Aoife | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 25,684 | — | $0 | 25,684 | SEC↗ |
| Cravatt Benjamin | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 25,684 | — | $0 | 25,684 | SEC↗ |
| EDWARDS JEFFREY L | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 25,684 | — | $0 | 25,684 | SEC↗ |
| Henderson Jeffrey William | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 25,684 | — | $0 | 25,684 | SEC↗ |
| Ho Maykin | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 25,684 | — | $0 | 25,684 | SEC↗ |
| Schoeneck James A | Director | A Award | 2022-06-16 | 2022-06-21 | 15,777 | — | $0 | 20,477 | SEC↗ |
| Lema Gerald | Director | A Award | 2022-06-16 | 2022-06-21 | 15,777 | — | $0 | 20,477 | SEC↗ |
| Blaug Suzanne | Director | A Award | 2022-06-16 | 2022-06-21 | 15,777 | — | $0 | 29,825 | SEC↗ |
| Brennan Aoife | Director | A Award | 2022-06-16 | 2022-06-21 | 15,777 | — | $0 | 24,391 | SEC↗ |
| Cravatt Benjamin | Director | A Award | 2022-06-16 | 2022-06-21 | 15,777 | — | $0 | 24,391 | SEC↗ |
| EDWARDS JEFFREY L | Director | A Award | 2022-06-16 | 2022-06-21 | 15,777 | — | $0 | 33,577 | SEC↗ |
| Henderson Jeffrey William | Director | A Award | 2022-06-16 | 2022-06-21 | 15,777 | — | $0 | 33,577 | SEC↗ |
| Ho Maykin | Director | A Award | 2022-06-16 | 2022-06-21 | 15,777 | — | $0 | 31,732 | SEC↗ |
| Wettig Thane | Chief Commercial Officer | F Tax w/h | 2022-06-06 | 2022-06-08 | 360 | $9.50 | $3.4K | 89,961 | SEC↗ |
| Conterno Enrique A | Chief Executive Officer | F Tax w/h | 2022-06-06 | 2022-06-08 | 1,772 | $9.50 | $16.8K | 301,940 | SEC↗ |
| Chung Christine | SVP, China Operations | F Tax w/h | 2022-06-06 | 2022-06-08 | 1,850 | $9.50 | $17.6K | 244,002 | SEC↗ |
| Eisner Mark | Chief Medical Officer | F Tax w/h | 2022-06-01 | 2022-06-03 | 1,141 | $9.61 | $11.0K | 149,800 | SEC↗ |
| Conterno Enrique A | Chief Executive Officer | F Tax w/h | 2022-04-07 | 2022-04-08 | 1,311 | $12.73 | $16.7K | 303,712 | SEC↗ |
| Eisner Mark | Chief Medical Officer | F Tax w/h | 2022-03-31 | 2022-04-01 | 6,442 | $12.02 | $77.4K | 150,941 | SEC↗ |
| Chung Christine | SVP, China Operations | F Tax w/h | 2022-03-31 | 2022-04-01 | 4,682 | $12.02 | $56.3K | 245,852 | SEC↗ |
| Wettig Thane | Chief Commercial Officer | F Tax w/h | 2022-03-22 | 2022-03-24 | 655 | $13.31 | $8.7K | 90,321 | SEC↗ |
| Conterno Enrique A | Chief Executive Officer | F Tax w/h | 2022-03-07 | 2022-03-09 | 7,081 | $12.69 | $89.9K | 305,023 | SEC↗ |
| Chung Christine | SVP, China Operations | F Tax w/h | 2022-03-07 | 2022-03-09 | 3,905 | $12.69 | $49.6K | 250,534 | SEC↗ |
| Wettig Thane | Chief Commercial Officer | F Tax w/h | 2022-03-07 | 2022-03-09 | 1,706 | $12.69 | $21.6K | 90,976 | SEC↗ |
| Eisner Mark | Chief Medical Officer | F Tax w/h | 2022-03-01 | 2022-03-03 | 756 | $13.62 | $10.3K | 157,383 | SEC↗ |
| Conterno Enrique A | Chief Executive Officer | A Award deriv | 2022-02-14 | 2022-02-16 | 298,000 | — | $0 | 298,000 | SEC↗ |
| Chung Christine | SVP, China Operations | A Award deriv | 2022-02-14 | 2022-02-16 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Eisner Mark | Chief Medical Officer | A Award deriv | 2022-02-14 | 2022-02-16 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Graham Juan | Chief Financial Officer | A Award deriv | 2022-02-14 | 2022-02-16 | 37,500 | — | $0 | 37,500 | SEC↗ |
| Wettig Thane | Chief Commercial Officer | A Award deriv | 2022-02-14 | 2022-02-16 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Conterno Enrique A | Chief Executive Officer | A Award | 2022-02-14 | 2022-02-16 | 179,400 | — | $0 | 312,104 | SEC↗ |
| Chung Christine | SVP, China Operations | A Award | 2022-02-14 | 2022-02-16 | 45,000 | — | $0 | 254,439 | SEC↗ |
| Eisner Mark | Chief Medical Officer | A Award | 2022-02-14 | 2022-02-16 | 60,000 | — | $0 | 158,139 | SEC↗ |
| Graham Juan | Chief Financial Officer | A Award | 2022-02-14 | 2022-02-16 | 22,500 | — | $0 | 58,900 | SEC↗ |
| Wettig Thane | Chief Commercial Officer | A Award | 2022-02-14 | 2022-02-16 | 45,000 | — | $0 | 92,682 | SEC↗ |
| Conterno Enrique A | Chief Executive Officer | F Tax w/h | 2022-01-06 | 2022-01-07 | 1,536 | $13.93 | $21.4K | 132,704 | SEC↗ |
| Chung Christine | SVP, China Operations | F Tax w/h | 2022-01-03 | 2022-01-05 | 5,284 | $14.82 | $78.3K | 209,439 | SEC↗ |
| Eisner Mark | Chief Medical Officer | F Tax w/h | 2022-01-03 | 2022-01-05 | 7,043 | $14.82 | $104.4K | 98,139 | SEC↗ |
| Wettig Thane | Chief Commercial Officer | F Tax w/h | 2021-12-22 | 2021-12-23 | 517 | $14.97 | $7.7K | 47,682 | SEC↗ |
| Chung Christine | SVP, China Operations | F Tax w/h | 2021-12-06 | 2021-12-08 | 2,668 | $14.19 | $37.9K | 214,723 | SEC↗ |
| Eisner Mark | Chief Medical Officer | F Tax w/h | 2021-12-01 | 2021-12-03 | 4,338 | $12.65 | $54.9K | 105,182 | SEC↗ |
| Conterno Enrique A | Chief Executive Officer | F Tax w/h | 2021-10-06 | 2021-10-08 | 1,859 | $10.20 | $19.0K | 134,239 | SEC↗ |
| Eisner Mark | Chief Medical Officer | A Award deriv | 2021-10-04 | 2021-10-06 | 44,520 | — | $0 | 44,520 | SEC↗ |
| Chung Christine | SVP, China Operations | A Award deriv | 2021-10-04 | 2021-10-06 | 32,360 | — | $0 | 32,360 | SEC↗ |
| Eisner Mark | Chief Medical Officer | A Award | 2021-10-04 | 2021-10-06 | 74,520 | — | $0 | 109,520 | SEC↗ |
| Chung Christine | SVP, China Operations | A Award | 2021-10-04 | 2021-10-06 | 54,170 | — | $0 | 217,391 | SEC↗ |
| Wettig Thane | Chief Commercial Officer | F Tax w/h | 2021-09-22 | 2021-09-24 | 620 | $10.18 | $6.3K | 48,196 | SEC↗ |
| KEARNS THOMAS F JR | Director | S Sale | 2021-09-15 | 2021-09-17 | 13,100 | $11.58 | $151.7K | 39,764 | SEC↗ |
| Graham Juan | Chief Financial Officer | A Award deriv | 2021-09-07 | 2021-09-09 | 196,000 | — | $0 | 196,000 | SEC↗ |
| Graham Juan | Chief Financial Officer | A Award | 2021-09-07 | 2021-09-09 | 35,000 | — | $0 | 36,400 | SEC↗ |
| Chung Christine | SVP, China Operations | F Tax w/h | 2021-09-07 | 2021-09-09 | 2,030 | $12.41 | $25.2K | 165,251 | SEC↗ |
| Cotroneo Pat | Executive Advisor & Former C | F Tax w/h | 2021-09-07 | 2021-09-09 | 2,141 | $12.41 | $26.6K | 274,536 | SEC↗ |
| Wettig Thane | Chief Commercial Officer | P Buy | 2021-08-26 | 2021-08-30 | 3,100 | $11.53 | $35.7K | 48,816 | SEC↗ |
| Conterno Enrique A | Chief Executive Officer | F Tax w/h | 2021-07-06 | 2021-07-08 | 1,859 | $25.06 | $46.6K | 136,098 | SEC↗ |
| Wettig Thane | Chief Commercial Officer | F Tax w/h | 2021-06-22 | 2021-06-24 | 2,593 | $27.65 | $71.7K | 45,716 | SEC↗ |
| Cotroneo Pat | SVP, Finance and CFO | S Sale | 2021-06-15 | 2021-06-17 | 4,053 | $25.62 | $103.8K | 276,677 | SEC↗ |
| Chung Christine | SVP, China Operations | F Tax w/h | 2021-06-07 | 2021-06-09 | 2,030 | $22.90 | $46.5K | 165,251 | SEC↗ |
| Cotroneo Pat | SVP, Finance and CFO | F Tax w/h | 2021-06-07 | 2021-06-09 | 2,141 | $22.90 | $49.0K | 280,730 | SEC↗ |
| Blaug Suzanne | Director | A Award deriv | 2021-05-26 | 2021-05-28 | 7,800 | — | $0 | 7,800 | SEC↗ |
| Brennan Aoife | Director | A Award deriv | 2021-05-26 | 2021-05-28 | 7,800 | — | $0 | 7,800 | SEC↗ |
| Cravatt Benjamin | Director | A Award deriv | 2021-05-26 | 2021-05-28 | 7,800 | — | $0 | 7,800 | SEC↗ |
| EDWARDS JEFFREY L | Director | A Award deriv | 2021-05-26 | 2021-05-28 | 7,800 | — | $0 | 7,800 | SEC↗ |
| Henderson Jeffrey William | Director | A Award deriv | 2021-05-26 | 2021-05-28 | 7,800 | — | $0 | 7,800 | SEC↗ |
| Ho Maykin | Director | A Award deriv | 2021-05-26 | 2021-05-28 | 7,800 | — | $0 | 7,800 | SEC↗ |
| KEARNS THOMAS F JR | Director | A Award deriv | 2021-05-26 | 2021-05-28 | 7,800 | — | $0 | 7,800 | SEC↗ |
| Kurkijarvi Kalevi | Director | A Award deriv | 2021-05-26 | 2021-05-28 | 7,800 | — | $0 | 7,800 | SEC↗ |
| Lema Gerald | Director | A Award deriv | 2021-05-26 | 2021-05-28 | 7,800 | — | $0 | 7,800 | SEC↗ |
| RIGGS RORY B | Director | A Award deriv | 2021-05-26 | 2021-05-28 | 7,800 | — | $0 | 7,800 | SEC↗ |
| Schoeneck James A | Director | A Award deriv | 2021-05-26 | 2021-05-28 | 7,800 | — | $0 | 7,800 | SEC↗ |
| Blaug Suzanne | Director | A Award | 2021-05-26 | 2021-05-28 | 4,700 | — | $0 | 14,048 | SEC↗ |
| Brennan Aoife | Director | A Award | 2021-05-26 | 2021-05-28 | 4,700 | — | $0 | 8,614 | SEC↗ |
| Cravatt Benjamin | Director | A Award | 2021-05-26 | 2021-05-28 | 4,700 | — | $0 | 8,614 | SEC↗ |
| EDWARDS JEFFREY L | Director | A Award | 2021-05-26 | 2021-05-28 | 4,700 | — | $0 | 17,800 | SEC↗ |
| Henderson Jeffrey William | Director | A Award | 2021-05-26 | 2021-05-28 | 4,700 | — | $0 | 17,800 | SEC↗ |
| Ho Maykin | Director | A Award | 2021-05-26 | 2021-05-28 | 4,700 | — | $0 | 15,955 | SEC↗ |
| KEARNS THOMAS F JR | Director | A Award | 2021-05-26 | 2021-05-28 | 4,700 | — | $0 | 52,864 | SEC↗ |
| Kurkijarvi Kalevi | Director | A Award | 2021-05-26 | 2021-05-28 | 4,700 | — | $0 | 37,800 | SEC↗ |
| Lema Gerald | Director | A Award | 2021-05-26 | 2021-05-28 | 4,700 | — | $0 | 9,400 | SEC↗ |
| RIGGS RORY B | Director | A Award | 2021-05-26 | 2021-05-28 | 4,700 | — | $0 | 395,750 | SEC↗ |
| Schoeneck James A | Director | A Award | 2021-05-26 | 2021-05-28 | 4,700 | — | $0 | 14,100 | SEC↗ |
| KEARNS THOMAS F JR | Director | M Exercise deriv | 2021-03-11 | 2021-03-15 | 6,000 | — | $0 | 0 | SEC↗ |
| KEARNS THOMAS F JR | Director | M Exercise deriv | 2021-03-11 | 2021-03-15 | 12,000 | — | $0 | 0 | SEC↗ |
| KEARNS THOMAS F JR | Director | S Sale | 2021-03-11 | 2021-03-15 | 18,000 | $35.02 | $630.4K | 148,164 | SEC↗ |
| KEARNS THOMAS F JR | Director | M Exercise | 2021-03-11 | 2021-03-15 | 18,000 | $3.50 | $63.0K | 166,164 | SEC↗ |
| Chung Christine | SVP, China Operations | F Tax w/h | 2021-03-08 | 2021-03-10 | 5,679 | $33.37 | $189.5K | 166,597 | SEC↗ |
| Cotroneo Pat | SVP, Finance and CFO | F Tax w/h | 2021-03-08 | 2021-03-10 | 5,657 | $33.37 | $188.8K | 282,187 | SEC↗ |
| Kouchakji Elias | SVP, Clinical Dev, Drug Safe | F Tax w/h | 2021-03-08 | 2021-03-10 | 5,221 | $33.37 | $174.2K | 147,346 | SEC↗ |
| Conterno Enrique A | Chief Executive Officer | A Award deriv | 2021-02-24 | 2021-02-26 | 164,000 | — | $0 | 164,000 | SEC↗ |
| Chung Christine | SVP, China Operations | A Award deriv | 2021-02-24 | 2021-02-26 | 41,700 | — | $0 | 41,700 | SEC↗ |
| Cotroneo Pat | SVP, Finance and CFO | A Award deriv | 2021-02-24 | 2021-02-26 | 41,700 | — | $0 | 41,700 | SEC↗ |